EncepHeal Therapeutics Competitors and Similar CompaniesClear all

EncepHeal Therapeutics's competitors and similar companies include Tiaki Therapeutics, Acumen Pharma, Neurolixis and VistaGen Therapeutics.
EncepHeal Therapeutics
EncepHeal Therapeutics
EncepHeal Therapeutics is a company that develops therapies for cocaine and methamphetamine addictions.
Tiaki Therapeutics
Tiaki Therapeutics
Tiaki Therapeutics is a company developing therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function.
Acumen Pharma
Acumen Pharma
Acumen Pharmaceuticals is a biopharmaceutical company that develops therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases.
Neurolixis
Neurolixis
Neurolixis is a biopharmaceutical company.
VistaGen Therapeutics
VistaGen Therapeutics
VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products.
Founding Date
Founding Date
2014
Founding Date
2017
Founding Date
1996
Founding Date
2011
Founding Date
1998
Type
Type
Private
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Winston-Salem, US HQ
Winston Salem, US
Locations
Cambridge, US HQ
Locations
Charlottesville, US HQ
Carmel, US
Locations
HQ
Locations
South San Francisco, US HQ
Employees
Employees
1
Employees
1
Employees
756% decrease
Employees
5
Employees
9
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
174.5 m
Valuation ($)
N/A
Valuation ($)
82.5 m

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($121.3m) (FY, 2025)
Net income
N/A
Net income
($51.4m) (FY, 2025)

Funding

Latest funding round
Latest funding round
$ 150k (almost 7 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 15k (almost 13 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 150k
Total funding raised
N/A
Total funding raised
$ 2.2m
Total funding raised
N/A
Total funding raised
$ 10m
For sources of this data, please see the company profile

View Company Profiles

Tiaki Therapeutics
HQ
Cambridge, US
Employees
1

Tiaki Therapeutics is a company developing therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function.

View company
Acumen Pharma
HQ
Charlottesville, US
Employees
7

Acumen Pharmaceuticals is a biopharmaceutical company that develops therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases.

View company
Neurolixis
HQ
Employees
5

Neurolixis is a biopharmaceutical company.

View company
VistaGen Therapeutics
HQ
South San Francisco, US
Employees
9

VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products.

View company